CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Option exercise Director acquired 12,668 shares (option exercise)
- 4 Option exercise Director acquired 12,668 shares (option exercise)
- 4 Option exercise Director acquired 12,668 shares (option exercise)
- 4 Option exercise Director acquired 12,668 shares (option exercise)
- 4 Option exercise Director acquired 22,565 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 6,041 shares (option exercise)
- 4 Option exercise Director acquired 17,565 shares (option exercise)
- 4 Open-market sale Executive VP Global Operations sold 40,000 shares at $11.01 ($440,320)
- SD Other Specialized Disclosure
- 4 Open-market sale Exec. VP Chief Legal Officer sold 37,884 shares at $10.22 ($387,125)
- 4 Option exercise See "Remarks" below acquired 37,884 shares (option exercise)
- 4 Open-market sale Executive VP, Global R&D sold 19,066 shares at $10.22 ($194,830)
- 4 Open-market sale Executive VP Global Operations sold 19,804 shares at $10.22 ($202,413)
Page 30 of 128 · 2,555 filings